Highlights and Quick Summary
- Total Assets for the quarter ending September 30, 2022 was $559 Million (a 9.41% increase compared to previous quarter)
- Year-over-year quarterly Total Assets decreased by -5.03%
- Annual Total Assets for 2021 was $588 Million (a 75.72% increase from previous year)
- Annual Total Assets for 2020 was $335 Million (a 90.96% increase from previous year)
- Annual Total Assets for 2019 was $175 Million (a 19.37% increase from previous year)
Visit stockrow.com/BCRX
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Total Assets of BioCryst Pharmaceuticals, Inc.
Most recent Total Assetsof BCRX including historical data for past 10 years.Interactive Chart of Total Assets of BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. Total Assets for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $558.59 | $510.54 | $527.72 | – |
| 2021 | $588.15 | $265.76 | $277.28 | $284.43 | $588.15 |
| 2020 | $334.72 | $176.23 | $214.71 | $136.59 | $334.72 |
| 2019 | $175.28 | $90.5 | $116.34 | $142.34 | $175.28 |
| 2018 | $146.84 | $168.31 | $136.64 | $155.37 | $146.84 |
| 2017 | $178.26 | $191.49 | $113.51 | $129.51 | $178.26 |
| 2016 | $89.85 | $91.5 | $82.22 | $102.88 | $89.85 |
| 2015 | $122.36 | $138.96 | $150.18 | $129.87 | $122.36 |
| 2014 | $136.87 | $137.13 | $141.98 | $43.39 | $136.87 |
| 2013 | $48.87 | $53.21 | $39.92 | $46.9 | $48.87 |
| 2012 | $57.44 | $64.09 | $76.24 | $80.09 | $57.44 |
Business Profile of BioCryst Pharmaceuticals, Inc.
Sector: Healthcare
Industry: Biotechnology